The Translocator Protein (<i>TSPO</i>) Genetic Polymorphism A147T Is Associated with Worse Survival in Male Glioblastoma Patients

The Translocator Protein (<i>TSPO</i>) Genetic Polymorphism A147T Is Associated with Worse Survival in Male Glioblastoma Patients

Glioblastoma (GBM) is the most common primary brain tumor in adults, with few available therapies and a five-year survival rate of 7.2%. Hence, strategies for improving GBM prognosis are urgently needed. The translocator protein 18kDa <i>(</i><i>TSPO</i>) plays crucial roles...

Full description

Bibliographic Details
Main Authors: Katie M. Troike, Arlet M. Acanda de la Rocha, Tyler J. Alban, Matthew M. Grabowski, Balint Otvos, Gino Cioffi, Kristin A. Waite, Jill S. Barnholtz Sloan, Justin D. Lathia, Tomás R. Guilarte, Diana J. Azzam
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Cancers
Subjects:
<i>TSPO</i>
biomarker
glioblastoma
single nucleotide polymorphism
survival
Online Access:https://www.mdpi.com/2072-6694/13/18/4525

Internet

https://www.mdpi.com/2072-6694/13/18/4525

Similar Items